Kathryn Payne

Senior Vice President of Corporate Communications and External Affairs at Orchard Therapeutics

About Kathryn

Katie Payne brings nearly 20 years of communications, stakeholder engagement and health policy expertise to Orchard Therapeutics as senior vice president of corporate communications and external affairs.

Her responsibilities at Orchard include directing the company’s internal and external communications, patient advocacy, investor relations and government relations functions. Katie joined Orchard from AMAG Pharmaceuticals, where she served as senior vice president of corporate affairs, overseeing all communications, government relations and advocacy activities. During her time at AMAG, Katie led the internal and external communications strategy for six significant corporate and business development transactions and played a key role in the company’s efforts to collaborate with healthcare experts and advocacy groups to advance public health. Her expertise includes stakeholder engagement, issues and crisis management, media relations and corporate identity. Prior to AMAG, Katie spent a decade at a global communications and public affairs firm where she developed and implemented U.S. and global communications programs for a wide variety of companies and organizations in the healthcare industry. She also served as a communications associate at The World Bank in Washington, D.C., and as a healthcare research associate for Forrester Research.

Katie graduated Phi Beta Kappa and with high honors from The Johns Hopkins University with a Bachelor of Arts degree in writing and business management and a master’s degree in communications. She currently serves as a member of the MassBio Board of Directors and is also a member of the Board of Directors of the Boston-Manchester March of Dimes chapter

See all Board Members